Emily D. Durden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily D. Durden has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Bong-Chul Chu
From Thomson Reuters (Dr Durden, Mr Huse, Dr Chu), Cambridge, MA; and Sanofi-aventis (Dr Ben-Joseph), Bridgewater, NJ
1 shared publicationDan Ma Huse
From Thomson Reuters (Dr Durden, Mr Huse, Dr Chu), Cambridge, MA; and Sanofi-aventis (Dr Ben-Joseph), Bridgewater, NJ
1 shared publicationRami Ben-Joseph
From Thomson Reuters (Dr Durden, Mr Huse, Dr Chu), Cambridge, MA; and Sanofi-aventis (Dr Ben-Joseph), Bridgewater, NJ
1 shared publication
Latest Publications
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 50 (9) , 991-997
Economic Costs of Obesity to Self-Insured Employers
Objective: To quantify the direct and indirect costs of obesity within a cohort of commercially insured employees in the United States. Method: Health plan claims, self-reported health risk assessment, and productivity data (Thomson MarketScan) from 2003 to 2005 were used to identify employees. Two-part regression models were used to compare body mass index (BMI) groups to estimate the incremental direct and indirect costs, conditional on expenditure, associated with elevated BMI. Results: Regression-adjusted incremental direct medical costs associated with being overweight, obese, and severely obese were estimated to be $147.11, $712.34, and $1977.43, respectively. Adjusted incremental indirect costs due to paid absence associated with being overweight, obese, and severely obese were estimated at $1403.81, $1511.24, and $1414.09, respectively. Conclusions: Overall adjusted direct and indirect costs were higher for workers with elevated BMI relative to those of normal weight.
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 50 (9) , 991-997
Economic Costs of Obesity to Self-Insured Employers
Objective: To quantify the direct and indirect costs of obesity within a cohort of commercially insured employees in the United States. Method: Health plan claims, self-reported health risk assessment, and productivity data (Thomson MarketScan) from 2003 to 2005 were used to identify employees. Two-part regression models were used to compare body mass index (BMI) groups to estimate the incremental direct and indirect costs, conditional on expenditure, associated with elevated BMI. Results: Regression-adjusted incremental direct medical costs associated with being overweight, obese, and severely obese were estimated to be $147.11, $712.34, and $1977.43, respectively. Adjusted incremental indirect costs due to paid absence associated with being overweight, obese, and severely obese were estimated at $1403.81, $1511.24, and $1414.09, respectively. Conclusions: Overall adjusted direct and indirect costs were higher for workers with elevated BMI relative to those of normal weight.